Works in Breast Cancer Research & Treatment, 2023, Vol 198, Issue 1


Results: 20
    1
    2
    3
    4
    5

    Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancer.

    Published in:
    Breast Cancer Research & Treatment, 2023, v. 198, n. 1, p. 67, doi. 10.1007/s10549-022-06856-1
    By:
    • Loft, Matthew;
    • Lok, Sheau Wen;
    • De Boer, Richard;
    • Malik, Laeeq;
    • Greenberg, Sally;
    • Yeo, Belinda;
    • Anton, Angelyn;
    • Nottage, Michelle;
    • Wong, Vanessa;
    • Nott, Louise;
    • Collins, Ian M.;
    • Torres, Javier;
    • Barnett, Frances;
    • Lombard, Janine M.;
    • Gibbs, Peter;
    • Gately, Lucy
    Publication type:
    Article
    6
    8
    9
    10
    11
    12
    13
    15
    16
    17
    18
    19
    20

    Time interval between diagnosis to treatment of breast cancer and the impact of health insurance coverage: a sub analysis of the AMAZONA III Study (GBECAM 0115).

    Published in:
    Breast Cancer Research & Treatment, 2023, v. 198, n. 1, p. 123, doi. 10.1007/s10549-022-06809-8
    By:
    • Maschmann, Raíra Mesquita;
    • De Jesus, Rafaela Gomes;
    • Werutsky, Gustavo;
    • Rebelatto, Taiane Francieli;
    • Queiroz, Geraldo;
    • Simon, Sergio Daniel;
    • Bines, José;
    • Barrios, Carlos Henrique Escosteguy;
    • Rosa, Daniela Dornelles
    Publication type:
    Article